Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011 (2011), Article ID 564521, 4 pages
http://dx.doi.org/10.1155/2011/564521
Case Report

Homicide and Associated Steroid Acute Psychosis: A Case Report

1Service de Médecine Légale, CHU d'Angers, 49933 Angers Cedex 09, France
2Département de Psychiatrie et de Psychologie médicale, CHU d'Angers, 49933 Angers Cedex 09, France
3IFR 132, Université d'Angers, 49035 Angers, France

Received 22 June 2011; Revised 26 August 2011; Accepted 26 September 2011

Academic Editor: Massimo Gallerani

Copyright © 2011 G. Airagnes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. H. Glaser, “Psychotic reactions induced by corticotropin (ACTH) cortisone,” Psychosomatic Medicine, vol. 15, no. 4, pp. 280–291, 1953. View at Google Scholar
  2. B. Wechsler and O. Chosidow, Corticoïdes et Corticothérapie, John Libbey Eurotext, Montrouge, France, 1997.
  3. J. P. Herman, M. M. Ostrander, N. K. Mueller, and H. Figueiredo, “Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 29, no. 8, pp. 1201–1213, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. E. S. Brown, D. A. Khan, and V. A. Nejtek, “The psychiatric side effects of corticosteroids,” Annals of Allergy, Asthma and Immunology, vol. 83, no. 6, part 1, pp. 495–504, 1999. View at Google Scholar · View at Scopus
  5. H. Schäcke, W.-D. Döcke, and K. Asadullah, “Mechanisms involved in the side effects of glucocorticoids,” Pharmacology and Therapeutics, vol. 96, no. 1, pp. 23–43, 2002. View at Publisher · View at Google Scholar
  6. S. B. Patten and C. I. Neutel, “Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management,” Drug Safety, vol. 22, no. 2, pp. 111–122, 2000. View at Google Scholar · View at Scopus
  7. A. J. Bradley and T. G. Dinan, “A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality,” Journal of Psychopharmacology, vol. 24, no. 4, pp. 91–118, 2010. View at Google Scholar
  8. C. M. Pariante, “Risk factors for development of depression and psychosis: glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids,” Annals of the New York Academy of Sciences, vol. 1179, pp. 144–152, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. O. M. Wolkowitz, H. Burke, E. S. Epel, and V. I. Reus, “Glucocorticoids: mood, memory, and mechanisms,” Annals of the New York Academy of Sciences, vol. 1179, pp. 19–40, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. S. Brown, “Effects of glucocorticoids on mood, memory, and the hippocampus: treatment and preventive therapy,” Annals of the New York Academy of Sciences, vol. 1179, pp. 41–55, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. T. P. Warrington and J. M. Bostwick, “Psychiatric adverse effects of corticosteroids,” Mayo Clinic Proceedings, vol. 81, no. 10, pp. 1361–1367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Cottencin, H. Legru, G. Vaiva, P. Thomas, and S. M. Consoli, “Corticosteroid-induced psychiatric episodes in consultation liaison psychiatry: personality and temperament assessments,” Presse Medicale, vol. 40, no. 2, pp. 203–209, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. Dorland’s Medical Dictionary for Health Consumers, Saunders, An Imprint of Elsevier, 2007.
  14. C. A. Naranjo, U. Busto, and E. M. Sellers, “A method for estimating the probability of adverse drug reactions,” Clinical Pharmacology and Therapeutics, vol. 30, no. 2, pp. 239–245, 1981. View at Google Scholar
  15. J. Halper, “Corticosteroids and behavioral disturbances,” in Principles of Corticosteroid Therapy, A. Lin and S. Paget, Eds., pp. 174–201, Arnold, London, UK, 2002. View at Google Scholar
  16. C. Trivalle, “Expression des principales maladies des personnes âgées,” in Geriatrie, J. Belmin, Ed., Elsevier Masson, Paris, France, 2nd edition, 2009. View at Google Scholar
  17. M. Bloch, E. Gur, and A. Shalev, “Chlorpromazine prophylaxis of steroid-induced psychosis,” General Hospital Psychiatry, vol. 16, no. 1, pp. 42–44, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. L. A. Davis, B. Merk, and P. G. Janicak, “Treatment of steroid psychoses,” Psychiatric Annals, vol. 22, no. 9, pp. 487–491, 1992. View at Google Scholar
  19. F. Sirois, “Steroid psychosis: a review,” General Hospital Psychiatry, vol. 25, no. 1, pp. 27–33, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Reckart and S. J. Eisendrath, “Exogenous corticosteroid effects on mood and cognition: case presentations,” International Journal of Psychosomatics, vol. 37, no. 1–4, pp. 57–61, 1990. View at Google Scholar · View at Scopus